Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old

The MONOD ANRS 12206 trial was designated to assess simplification of a successful lopinavir (LPV)-based antiretroviral treatment in HIV-infected children younger than 3 years of age using efavirenz (EFV; 25 mg/kg of body weight/day) to preserve the class of protease inhibitors for children in that...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Pressiat, Claire, Amorissani-Folquet, Madeleine, Yonaba, Caroline, Treluyer, Jean-Marc, Dahourou, Désiré Lucien, Eboua, François, Blanche, Stéphane, Mea-Assande, Véronique, Bouazza, Naïm, Foissac, Frantz, Malateste, Karen, Ouedraogo, Sylvie, Lui, Gabrielle, Leroy, Valériane, Hirt, Déborah
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5487686/
https://ncbi.nlm.nih.gov/pubmed/28483965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00297-17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars